MICHELLE SNYDER: Open Payments
NPI 1053021717 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 61 payments from 14 companies in 2025. Trend: 2023 $736 · 2024 $1,599 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 13 | $267 |
| AstraZeneca Pharmaceuticals LP | 9 | $235 |
| GENZYME CORPORATION | 7 | $174 |
| GlaxoSmithKline, LLC. | 9 | $141 |
| SCPHARMACEUTICALS INC. | 1 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| BioCryst US Sales Co., LLC | 5 | $99 |
| Grifols USA, LLC | 2 | $54 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $52 |
| Pharming Healthcare, Inc. | 2 | $46 |
Products named: DUPIXENT, Andembry, FUROSCIX, TEZSPIRE, ORLADEYO, NUCALA, TRELEGY ELLIPTA, FASENRA.
Industry payments across NC — which companies pay providers there.
